Dendritic Cell Therapy in Composite Tissue Allotransplantation

Transplantation Proceedings

Volumn 41, Issue 2, 2009, Pages 537-538

  Thomson, A W ^a   Sacks, J M ^a   Kuo, Y R ^a   Ikeguchi, R ^a   Horibe, E K ^a   Unadkat, J ^a   Solari, M G ^a   Feili Hariri, M ^a   Lee, W P A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RAPAMYCIN;

ALLOTRANSPLANTATION; ARTICLE; CELL THERAPY; COMPOSITE GRAFT; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

BONE MARROW CELLS; DENDRITIC CELLS; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; SPLEEN; T-LYMPHOCYTES; TISSUE TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 62849108696     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.011     Document Type: Article

References (16)

1. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685
2. Morelli A.E., and Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7 (2007) 610
3. Wang Z., Larregina A.T., Shufesky W.J., et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 6 (2006) 1297
4. Zahorchak A.F., Kean L.S., Tokita D., et al. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 84 (2007) 196
5. McCurry K.R., Colvin B.L., Zahorchak A.F., et al. Regulatory dendritic cell therapy in organ transplantation. Transpl Int 19 (2006) 525
6. Dhodapkar M.V., Steinman R.M., Krasovsky J., et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193 (2001) 233
7. Dhodapkar M.V., and Steinman R.M. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100 (2002) 174
8. Hackstein H., and Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (2004) 24
9. Kenna T.J., Thomas R., and Steptoe R.J. Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses. Blood 111 (2008) 2091
10. Sacks J.M., Kuo Y.R., Taieb A., et al. Prolongation of composite tissue allograft survival by immature recipient dendritic cells pulsed with donor antigen and transient low-dose immunosuppression. Plast Reconstr Surg 121 (2008) 37
11. + T regulatory cells and promote organ transplant tolerance. J Immunol 178 (2007) 7018
12. Ikeguchi R., Sacks J.M., Unadkat J.V., et al. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Transplantation 85 (2008) 237
13. Horibe E.K., Sacks J., Unadkat J., et al. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl Immunol 18 (2008) 307
14. Garrovillo M., Ali A., and Oluwole S.F. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 68 (1999) 1827
15. Oluwole O.O., Depaz H.A., Gopinathan R., et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 50 (2001) 1546
16. Taner T., Hackstein H., Wang Z., et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am J Transplant 5 (2005) 228